SCHEMBL19818

SCHEMBL19818

COCCOC(=O)C1(OCCOC)CCC(c2cc(NCOCC[Si](C)(C)C)n3nccc3n2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE10A Q9Y233 4/20 0.41
▸ CDK9 P50750 3/20 0.31
▸ CDK2 P24941 2/20 0.31
▸ CDK7 P50613 2/20 0.31
▸ CDK13 Q14004 1/20 0.31
▸ CDK12 Q9NYV4 1/20 0.31
▸ PRKAB2 O43741 1/20 0.30
▸ PRKAG1 P54619 1/20 0.30
▸ PRKAA2 P54646 1/20 0.30
▸ PRKAA1 Q13131 1/20 0.30
▸ PRKAG3 Q9UGI9 1/20 0.30
▸ PRKAG2 Q9UGJ0 1/20 0.30
▸ PRKAB1 Q9Y478 1/20 0.30
▸ CCNT1 O60563 2/20 0.30
▸ DGAT1 O75907 1/20 0.30
▸ GSK3B P49841 1/20 0.30
▸ MAPKAPK2 P49137 1/20 0.30
▸ CCNH P51946 1/20 0.30
▸ CCNE1 P24864 1/20 0.30
▸ KCNN3 Q9UGI6 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL40556 0.87 HSD17B10 (0.33) GSK3B
SCHEMBL21222 0.85 CRHR1 (0.31) —
SCHEMBL42979 0.82 CDK2 (0.43) PDE10ACDK9CDK2CDK7CDK13
SCHEMBL47762 0.81 CHEK1 (0.38) CDK2DGAT1
SCHEMBL30813 0.78 CRHR1 (0.31) —
SCHEMBL10209999 0.78 PDE10A (0.53) PDE10ACDK9CDK2CDK7CDK13
SCHEMBL39693 0.78 PDE10A (0.50) PDE10ACDK9CDK2CDK7CDK13
SCHEMBL10210928 0.77 PDE10A (0.49) PDE10ACDK9CDK2CDK7CDK13
SCHEMBL47770 0.77 PDE10A (0.49) PDE10ACDK9CDK2CDK7CDK13
SCHEMBL20634 0.74 KDM4E (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2608669-B1 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS MERCK SHARP & DOHME (US) 2016-06-22 — — EP disclosed
EP-2608668-B1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN MERCK SHARP & DOHME (US) 2016-06-01 — — EP disclosed
WO-2012027234-A1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN SCHERING CORPORATION (US) 2012-03-01 — — WO disclosed
WO-2012027236-A1 NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS SCHERING CORPORATION (US) 2012-03-01 — — WO disclosed
Send feedback